Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Other Non-Current Assets (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Other Non-Current Assets for 3 consecutive years, with $7.6 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 12.51% to $7.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 million through Dec 2025, up 12.51% year-over-year, with the annual reading at $7.6 million for FY2025, 12.51% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $7.6 million at Nuvation Bio, up from $7.5 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $7.6 million in Q4 2025, with the low at $138000.0 in Q1 2023.
  • Average Other Non-Current Assets over 3 years is $3.2 million, with a median of $1.1 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets rose 4.35% in 2024, then soared 5081.94% in 2025.
  • Over 3 years, Other Non-Current Assets stood at $587000.0 in 2023, then surged by 1051.79% to $6.8 million in 2024, then grew by 12.51% to $7.6 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods came in at $7.6 million, $7.5 million, and $6.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.